Related Experiment Video

Updated: May 31, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

The multifactorial origin of growth failure in thalassaemia

Nicos Skordis1, Andreas Kyriakou

  • 1Paediatric Endocrine Unit, Makarios Hospital, Nicosia 1474, Cyprus. nskordis@cytanet.com.cy

Pediatric Endocrinology Reviews : PER
|June 28, 2011
PubMed

Insights

Growth failure in thalassaemia major (TM) is multifactorial, stemming from iron overload and endocrine damage. Despite advances, short stature and delayed puberty remain significant challenges for TM patients.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Hematology

Background:

  • Growth failure is a persistent complication in thalassaemia major (TM) despite therapeutic advancements.
  • TM patients exhibit a distinct growth pattern, with normal growth until age 9-10, followed by slowed velocity and absent pubertal growth spurts.

Purpose of the Study:

  • To elucidate the multifactorial pathogenesis of growth failure in thalassaemia major.
  • To identify key contributing factors and phases of growth disturbances in TM.

Main Methods:

  • Review of existing literature on growth disturbances in thalassaemia major.
  • Analysis of the impact of iron overload, endocrine dysfunction, and pubertal delay on growth in TM.

Main Results:

  • Growth failure in TM is multifactorial, primarily due to iron overload damaging endocrine glands and dysregulation of the GH-IGF-1 axis.
  • Three distinct phases of growth disturbances are recognized, with varying etiologies related to age, anemia, hypoxia, and pubertal status.
  • Even with intensive chelation therapy, TM children and adolescents often remain short with disproportionate body segments.

Conclusions:

  • Growth retardation remains a significant challenge in thalassaemia major, impacting quality of life.
  • Addressing endocrine complications and pubertal delay is crucial for improving growth outcomes in TM patients.

More Related Videos

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...